FLAXEDIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Flaxedil, and when can generic versions of Flaxedil launch?
Flaxedil is a drug marketed by Davis And Geck and is included in one NDA.
The generic ingredient in FLAXEDIL is gallamine triethiodide. Additional details are available on the gallamine triethiodide profile page.
Summary for FLAXEDIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 98 |
Patent Applications: | 287 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FLAXEDIL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for FLAXEDIL
US Patents and Regulatory Information for FLAXEDIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Davis And Geck | FLAXEDIL | gallamine triethiodide | INJECTABLE;INJECTION | 007842-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Davis And Geck | FLAXEDIL | gallamine triethiodide | INJECTABLE;INJECTION | 007842-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |